Is Adlai Nortye Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ANL) stock is to Buy ANL stock.
Out of 1 analyst, 0 (0%) are recommending ANL as a Strong Buy, 1 (100%) are recommending ANL as a Buy, 0 (0%) are recommending ANL as a Hold, 0 (0%) are recommending ANL as a Sell, and 0 (0%) are recommending ANL as a Strong Sell.
What is ANL's earnings growth forecast for 2025-2025?
(NASDAQ: ANL) Adlai Nortye's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 31.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 66.53%.
Adlai Nortye's earnings in 2025 is -$54,065,000.
In 2025, ANL is forecast to generate -$101,844,741 in earnings, with the lowest earnings forecast at -$101,844,741 and the highest earnings forecast at -$101,844,741.
What is ANL's forecast return on equity (ROE) for 2025-2026?
(NASDAQ: ANL) forecast ROE is -205.35%, which is considered weak.
What is ANL's Price Target?
According to 1 Wall Street analyst that have issued a 1 year ANL price target, the average ANL price target is $9.00, with the highest ANL stock price forecast at $9.00 and the lowest ANL stock price forecast at $9.00.
The Wall Street analyst predicted that Adlai Nortye's share price could reach $9.00 by Nov 11, 2025. The average Adlai Nortye stock price prediction forecasts a potential upside of 354.55% from the current ANL share price of $1.98.
What is ANL's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ANL) Adlai Nortye's current Earnings Per Share (EPS) is $0.93. In 2025, ANL's EPS is forecast to hit -$0.92 (min: -$0.92, max: -$0.92).
What is ANL's forecast return on assets (ROA) for 2025-2026?
(NASDAQ: ANL) forecast ROA is -101.78%, which is lower than the forecast US Biotechnology industry average of 985.04%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.